FTO negatively regulates the expression of Ankyrin Repeat and SOCS Box Containing 2 (ASB2) and Retinoic Acid Receptor Alpha (RARA), a cluster tumor suppressor target gene, by post-transcriptionally modulating its m6A abundance and then affecting its stability [31]. This evidence concerns the gene FTO and neoplasm.